COMPOSITION | |
---|---|
Rabeprazole | 20MG |
Domperidone | 10MG |
Rabeprazole Domperidone
RABEVIB D
SPECIFICATION | |
---|---|
FORM | TABLET |
PACKING | 10×10 |
PACKING TYPE | ALU ALU |
MRP | 790 |
DESCRIPTION
Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug – in the acid environment of the parietal cells it turns into active sulphenamide form. Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastric acid secretion.
A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms. [PubChem]
SIDE EFFECTS
N/A
Side effects include galactorrhea, gynecomastia, or menstrual irregularities.
INDICATION
Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug – in the acid environment of the parietal cells it turns into active sulphenamide form. Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastric acid secretion.
For management of dyspepsia, heartburn, epigastric pain, nausea, and vomiting.